SYMPTOMS, COMPLICATIONS AND PROPER MANAGEMENT OF BRONCHIOLITIS IN CHILDREN

This article aims to review current knowledge of bronchiolitis in children, especially those till 12 months due to high prevalence in them. As well several management methods are emphasized. Literature search using MEDLINE, Embase and CENTRAL was conducted throughout 2018 for all types of studies including clinical, reviews, meta-analysis studies and observational studies that reported the management of bronchiolitis in children. Acute bronchiolitis is the most widespread reduced respiratory system tract disease in infants and children, and is usually the outcome of viral infection. Respiratory syncytial virus (RSV) is the most constant contaminating agent. Bronchodilators are not constantly efficient, however might have some advantage in chosen patients. If offered to patients with bronchiolitis, their usage needs to just be continued if unbiased measures demonstrate improvement in the patients oxygenation or work of breathing. Corticosteroids have not been shown to be effective and are not suggested for routine use. Ribavirin is not suggested for regular usage in patients with bronchiolitis, although it may be of advantage in immunocompromised patients. Antibiotics need to only be utilized in the presence of a validated bacterial infection.